These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19847629)

  • 21. Non-compartmental estimation of pharmacokinetic parameters for flexible sampling designs.
    Jaki T; Wolfsegger MJ
    Stat Med; 2012 May; 31(11-12):1059-73. PubMed ID: 21969306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal design for linear interpolation of curves.
    Wang J
    Stat Med; 2001 Aug; 20(16):2467-77. PubMed ID: 11512136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A sequential Monte Carlo approach to derive sampling times and windows for population pharmacokinetic studies.
    McGree JM; Drovandi CC; Pettitt AN
    J Pharmacokinet Pharmacodyn; 2012 Oct; 39(5):519-26. PubMed ID: 22847735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bootstrap approach for constructing confidence intervals for population pharmacokinetic parameters. I: A use of bootstrap standard error.
    Yafune A; Ishiguro M
    Stat Med; 1999 Mar; 18(5):581-99. PubMed ID: 10209813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interpretation of simulation studies for efficient estimation of population pharmacokinetic parameters.
    Ette EI; Kelman AW; Howie CA; Whiting B
    Ann Pharmacother; 1993 Sep; 27(9):1034-9. PubMed ID: 8117353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determining the error of dose estimates and minimum and maximum acceptable concentrations from assays with nonlinear dose-response curves.
    Gottschalk PG; Dunn JR
    Comput Methods Programs Biomed; 2005 Dec; 80(3):204-15. PubMed ID: 16256244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bootstrap method-based estimation of the minimum sample number for obtaining pharmacokinetic parameters in preclinical experiments.
    Takemoto S; Yamaoka K; Nishikawa M; Yano Y; Takakura Y
    J Pharm Sci; 2010 Apr; 99(4):2176-84. PubMed ID: 19902519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of the Size of Cohorts in Adaptive Design for Nonlinear Mixed Effects Models: An Evaluation by Simulation for a Pharmacokinetic and Pharmacodynamic Model for a Biomarker in Oncology.
    Lestini G; Dumont C; Mentré F
    Pharm Res; 2015 Oct; 32(10):3159-69. PubMed ID: 26123680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some considerations on the design of population pharmacokinetic studies.
    Duffull S; Waterhouse T; Eccleston J
    J Pharmacokinet Pharmacodyn; 2005 Aug; 32(3-4):441-57. PubMed ID: 16284917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic parameters estimation using adaptive Bayesian P-splines models.
    Jullion A; Lambert P; Beck B; Vandenhende F
    Pharm Stat; 2009; 8(2):98-112. PubMed ID: 18481279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Balanced designs in longitudinal population pharmacokinetic studies.
    Ette EI; Sun H; Ludden TM
    J Clin Pharmacol; 1998 May; 38(5):417-23. PubMed ID: 9602953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved pharmacokinetic and bioavailability support of drug discovery using serial blood sampling in mice.
    Peng SX; Rockafellow BA; Skedzielewski TM; Huebert ND; Hageman W
    J Pharm Sci; 2009 May; 98(5):1877-84. PubMed ID: 18803263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simulation for clinical repeated-dose pharmacokinetic trials applying a peak-and-trough sampling design to estimate oral clearance.
    Ishida K; Kayano Y; Taguchi M; Hashimoto Y
    Biol Pharm Bull; 2007 Nov; 30(11):2159-62. PubMed ID: 17978492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models.
    Bulitta JB; Landersdorfer CB
    AAPS J; 2011 Jun; 13(2):212-26. PubMed ID: 21374103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of multiple-trough sampling design and algorithm on the estimation of population and individual pharmacokinetic parameters].
    Ling J; Qian LX; Ding JJ; Jiao Z
    Yao Xue Xue Bao; 2014 May; 49(5):686-94. PubMed ID: 25151742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimising time samples for determining area under the curve of pharmacokinetic data using non-compartmental analysis.
    Hughes JH; Upton RN; Reuter SE; Phelps MA; Foster DJR
    J Pharm Pharmacol; 2019 Nov; 71(11):1635-1644. PubMed ID: 31412422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An estimation method of the half-life for a one-compartment model of a single bolus intravenous injection by a single sampling.
    Funatogawa T; Funatogawa I; Yafune A
    J Biopharm Stat; 2007; 17(5):827-37. PubMed ID: 17885868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative performance of different stochastic methods to simulate drug exposure and variability in a population.
    Tam VH; Kabbara S
    Diagn Microbiol Infect Dis; 2006 Oct; 56(2):185-8. PubMed ID: 16930922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic design optimization in children and estimation of maturation parameters: example of cytochrome P450 3A4.
    Bouillon-Pichault M; Jullien V; Bazzoli C; Pons G; Tod M
    J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):25-40. PubMed ID: 21046208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimators and confidence intervals for the proportion using binary auxiliary information with applications to pharmaceutical studies.
    Rueda M; Muñoz JF; Arcos A; Álvarez E; Martínez S
    J Biopharm Stat; 2011 May; 21(3):526-54. PubMed ID: 21442524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.